How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom
Investor's Business DailyAbbott Laboratories launched its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.
The post How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom appeared first on Investor�…